These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3512121

  • 1. Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.
    Mettauer B, Rouleau JL, Bichet D, Kortas C, Manzini C, Tremblay G, Chatterjee K.
    Circulation; 1986 Mar; 73(3):492-502. PubMed ID: 3512121
    [Abstract] [Full Text] [Related]

  • 2. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J, Cody RJ, Laragh JH.
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [Abstract] [Full Text] [Related]

  • 3. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
    Sharpe DN, Coxon R.
    Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
    [Abstract] [Full Text] [Related]

  • 4. Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure.
    Bichet DG, Kortas C, Mettauer B, Manzini C, Marc-Aurèle J, Rouleau JL, Schrier RW.
    Kidney Int; 1986 Jun; 29(6):1188-96. PubMed ID: 3528612
    [Abstract] [Full Text] [Related]

  • 5. Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.
    Stein L, Henry DP, Weinberger MH.
    Am J Med; 1981 Apr; 70(4):825-32. PubMed ID: 7011023
    [Abstract] [Full Text] [Related]

  • 6. Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.
    Riegger GA, Kochsiek K.
    Am J Cardiol; 1986 Aug 01; 58(3):300-3. PubMed ID: 3526857
    [Abstract] [Full Text] [Related]

  • 7. Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment.
    Riegger GA, Haeske W, Kraus C, Kromer EP, Kochsiek K.
    Am J Cardiol; 1987 Apr 01; 59(8):906-10. PubMed ID: 3548307
    [Abstract] [Full Text] [Related]

  • 8. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.
    Creager MA, Faxon DP, Cutler SS, Kohlmann O, Ryan TJ, Gavras H.
    J Am Coll Cardiol; 1986 Apr 01; 7(4):758-65. PubMed ID: 3514728
    [Abstract] [Full Text] [Related]

  • 9. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
    Bayliss J, Canepa-Anson R, Norell MS, Poole-Wilson P, Sutton G.
    Br Heart J; 1986 Mar 01; 55(3):265-73. PubMed ID: 3513808
    [Abstract] [Full Text] [Related]

  • 10. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study.
    Schofer J, Hobuss M, Aschenberg W, Tews A.
    Eur Heart J; 1990 Aug 01; 11(8):712-21. PubMed ID: 1975780
    [Abstract] [Full Text] [Related]

  • 11. Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure.
    Packer M, Medina N, Yushak M.
    J Am Coll Cardiol; 1986 Mar 01; 7(3):671-80. PubMed ID: 2869077
    [Abstract] [Full Text] [Related]

  • 12. Neurohumoral and hemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms.
    Rouleau JL, Kortas C, Bichet D, de Champlain J.
    Am Heart J; 1988 Sep 01; 116(3):746-57. PubMed ID: 2970771
    [Abstract] [Full Text] [Related]

  • 13. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
    Silberbauer K, Punzengruber C, Sinzinger H.
    Cardiology; 1983 Sep 01; 70(6):297-307. PubMed ID: 6370431
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
    Packer M, Medina N, Yushak M.
    Am J Cardiol; 1984 Oct 01; 54(7):771-7. PubMed ID: 6091434
    [Abstract] [Full Text] [Related]

  • 15. Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
    Sharpe DN, Coxon R.
    Aust N Z J Med; 1982 Oct 01; 12(5):483-8. PubMed ID: 6758746
    [Abstract] [Full Text] [Related]

  • 16. [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
    Kawahara Y, Hasegawa K, Sawayama T, Inoue S, Nakamura T, Kakumae S, Tadaoka S, Nakao M, Nezuo S.
    Kokyu To Junkan; 1989 Dec 01; 37(12):1333-40. PubMed ID: 2575781
    [Abstract] [Full Text] [Related]

  • 17. Captopril does not prevent nitroglycerin tolerance in heart failure.
    Dupuis J, Lalonde G, Bichet D, Rouleau JL.
    Can J Cardiol; 1990 Sep 01; 6(7):281-6. PubMed ID: 2121325
    [Abstract] [Full Text] [Related]

  • 18. Intravenous captopril in congestive heart failure.
    Ahmad S, Giles TD, Roffidal LE, Haney Y, Given MB, Sander GE.
    J Clin Pharmacol; 1990 Jul 01; 30(7):609-14. PubMed ID: 2202753
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.
    Cleland J, Semple P, Hodsman P, Ball S, Ford I, Dargie H.
    Am J Med; 1984 Nov 01; 77(5):880-6. PubMed ID: 6388325
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.